Lupin’s formulation manufacturing facilities at Goa and Indore (Pithampur Unit II), has received warning letter from USFDA. Earlier, Lupin received 3 Form 483 observations in Goa on...
Lupin receives final approval for its testosterone topical solution from the US health regulator. In a BSE filing Lupin stated, “The company has received final...